JP Morgan Chase’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.31M Buy
192,500
+135,900
+240% +$5.84M ﹤0.01% 2868
2026
Q1
$2M Sell
56,600
-224,900
-80% -$10.7M ﹤0.01% 4101
2025
Q4
$14.3M Sell
281,500
-251,400
-47% -$12.9M ﹤0.01% 2366
2025
Q3
$29.6M Buy
+532,900
New +$31.2M ﹤0.01% 1778
2025
Q2
Sell
-315,200
Closed -$21.9M 7479
2025
Q1
$21.9M Buy
+315,200
New +$26M ﹤0.01% 1863
2023
Q4
Sell
-5,400
Closed -$491K 7765
2023
Q3
$491K Sell
5,400
-254,800
-98% -$22.4M ﹤0.01% 4492
2023
Q2
$21.1M Buy
260,200
+201,400
+343% +$16.5M ﹤0.01% 1662
2023
Q1
$4.68M Buy
58,800
+53,800
+1,076% +$3.81M ﹤0.01% 2875
2022
Q4
$338K Buy
+5,000
New +$293K ﹤0.01% 4754
2022
Q3
Sell
-4,800
Closed -$267K 6731
2022
Q2
$267K Buy
+4,800
New +$266K ﹤0.01% 4924
2021
Q2
Sell
-60,000
Closed -$2.02M 6530
2021
Q1
$2.02M Buy
+60,000
New +$2.14M ﹤0.01% 3717
2019
Q3
Sell
-120,800
Closed -$3.07M 5887
2019
Q2
$3.07M Buy
+120,800
New +$2.99M ﹤0.01% 3060

Other funds holding NVO

JP Morgan Chase's NVO Position: Q2 2026 in Review

JP Morgan Chase reduced its Novo Nordisk (NVO) stake by 43% in Q2 2026, selling an estimated $51.4M and leaving 1,612,426 shares worth $77.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

JP Morgan Chase first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $722M in Q1 2024. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • JP Morgan Chase held 1,612,426 shares of Novo Nordisk worth $77.9M as of Q2 2026.
  • JP Morgan Chase sold 1,196,392 Novo Nordisk shares in Q2 2026, an estimated $51.4M.
  • Novo Nordisk made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1193 holding.
  • JP Morgan Chase first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Novo Nordisk position peaked at $722M in Q1 2024.
  • 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.